Vitamin Loaded Glyconanoparticle Formulation Service
Overview
Vitamins are essential for metabolism, growth, development, and proper functioning of the body, and they need to be obtained from food. They improve the body's immunity and vision, enhance skin health, help prevent the onset of various diseases, maintain healthy skin, and accelerate wound healing. To improve their stability and bioavailability, nanotechnology has been applied to the proper delivery of vitamins. Glyconanoparticles are ideal carriers for active ingredients such as vitamins due to their unique chemical and physical properties. Relying on the cutting-edge GlycoNano™ Platform, CD BioGlyco offers a one-stop vitamin-loaded glyconanoparticle formulation service. We develop nanoproducts with excellent properties to meet the needs of food, nutraceuticals, cosmetics, and other fields.
State-of-the-art Customized Vitamin Loaded Glyconanoparticle Formulation Service
Vitamins are encapsulated in glyconanoparticles to form nano complexes with specific functions and properties through precise formulation design and optimized preparation processes. They improve the absorption and utilization efficiency of vitamins in the body and achieve targeted delivery and precise release. Specific Glyconanoparticle Formulation services include the following:
Glyconanoparticle Development
We have in-depth communication with our clients to understand their needs, goals, and practical application directions. Based on the experimental objectives, we design a rational glyconanoparticle formulation and use advanced technology to prepare the glyconanoparticle for vitamin encapsulation. During the preparation process, we optimize them to ensure that their loading, stability, and bioavailability meet the requirements. Developable glyconanoparticles include the following:
| Glyconanoparticles | |
|---|---|
Glyconanoparticle Characterization
A systematic and comprehensive analysis of the Physicochemical Properties and Interactions of glyconanoparticles. The comprehensive characterization and analysis provide an important basis for the application research of glyconanoparticles.
- Particle size and morphology: The particle size distribution and morphology of glyconanoparticles are measured by dynamic light scattering (DLS), transmission electron microscopy (TEM), scanning electron microscopy (SEM), and other techniques.
- Surface charge: We determine the zeta potential of glyconanoparticles to better analyze their stability.
- Structure: Techniques such as nuclear magnetic resonance (NMR) are used to determine the detailed energetic groups and chemical structure of glyconanoparticles, which is important for understanding their biological activity and targeting.
- Interactions: Techniques such as SPR are used to analyze the binding affinity and interactions of the prepared glyconanoparticles to provide a basis for applied research.
Glyconanoparticle Preclinical Study
We utilize various cell and animal models to study the safety and efficacy of glyconanoparticle in delivering vitamins, including but not limited to the following:
- Embedding efficiency and drug loading: Using a variety of analytical methods, we accurately determine the encapsulation efficiency and drug loading capacity of the vitamins to ensure efficient loading in the glyconanoparticle, thereby greatly enhancing bioavailability.
- Release kinetics: We simulate the in vivo environment to study the release kinetics of vitamins in depth and evaluate the release pattern under different conditions to provide a scientific basis for targeted delivery and controlled release design.
- Stability analysis: We conduct detailed studies on the stability of glyconanoparticles by simulating different environmental conditions.
- Targeting: We use techniques such as fluorescent labeling, isotope labeling, etc., to track the distribution and metabolism of glyconanoparticles in organisms. Its targeting ability to specific cells, tissues, etc., is also studied to understand its potential as a vitamin carrier.
- Pharmacokinetic Study: The absorption, distribution, metabolism, and excretion of glyconanoparticles in organisms are studied by measuring tissue distribution, metabolites, etc., at different times.
- Safety Pharmacology evaluation: We study and assess acute toxicity, long-term toxicity, neurotoxicity, reproductive toxicity, etc., of glyconanoparticles.
Encapsulate vitamins include the following types:
Vitamin A
Vitamin D
Vitamin E
Vitamin K
Vitamin C
Vitamin B1 (thiamine)
Vitamin B2 (riboflavin)
Vitamin B3 (niacin)
Vitamin B5 (pantothenic acid)
Vitamin B6 (pyridoxine)
Vitamin B7 (biotin)
Vitamin B9 (folate)
Vitamin B11 (folic acid)
Vitamin B12 (cobalamin)
Workflow
We provide our clients with innovative, efficient, and customized solutions for designing the right formulation of glyconanoparticle for encapsulated vitamins and studying in detail the efficiency and safety of its delivery.

Applications
- In food, the vitamin is encapsulated in glyconanoparticles to enhance the nutritional value of functional foods.
- In cosmetics, the vitamin is encapsulated in glyconanoparticles to enhance its absorption capacity and improve skin condition.
- In nutraceuticals, as a functional nutraceutical ingredient, the vitamin is encapsulated in a glyconanoparticle to enhance the utilization value.
Advantages
- Our glyconanoparticle team consists of experienced scientists and researchers who are well-versed in nanotechnology and pharmacology.
- We specialize in creating customized vitamin-loaded glyconanoparticle formulation solutions to precisely fit different project objectives.
- We are equipped with state-of-the-art laboratory equipment and research techniques to ensure high-precision analysis of glyconanoparticles.
Publication Data
Technology: Nanotechnology
Journal: Frontiers in Nutrition
IF: 5
Published: 2022
Results: In this paper, nanomaterials for encapsulation of vitamins and carotenoids and their biocompatibility are systematically discussed. The biocompatible nanoparticles developed so far include polysaccharide-based nanoparticles, lipid-based nanocarriers, etc. They have good applications in delivering these active substances (essential fatty acids, oil-soluble vitamins, phytosterols, etc.) by improving their stability and solubility, enhancing absorption, increasing in vivo circulation time, and preventing premature degradation.
Frequently Asked Questions
- What are the advantages of the developed glyconanoparticle?
- Efficient loading: Optimization of the glyconanoparticle formulation and preparation process enables efficient loading of vitamins and improves product efficacy.
- Good stability: Glyconanoparticle has excellent stability, which protects the vitamins from the external environment and extends the shelf life of the product.
- High bioavailability: Glyconanoparticles encapsulate vitamins to enhance their absorption and utilization in the body.
- Targeted: Through surface modification and other means, it is possible to achieve targeted delivery of vitamins and improve the efficacy of the product.
- How do you ensure the quality of glyconanoparticle formulation?
We design suitable glyconanoparticle formulations based on client needs and objectives and adopt advanced nano-preparation technology to strictly control the reaction conditions and optimize its particle size distribution and stability. At the same time, we conduct detailed characterization and preclinical studies on the prepared glyconanoparticle, including particle size distribution, bioavailability, targeting, etc., to ensure that its quality meets the relevant standards and practical applications.
At CD BioGlyco, our vitamin-loaded glyconanoparticle formulation services offer a wide range of applications and technical advantages. We continuously optimize our formulation design, preparation process, and performance testing methods to ensure that glyconanoparticle formulation meets the requirements. Please feel free to contact us for detailed project information, should you need this area.
Reference
- Ranjha, M.M.A.N.; et al. Biocompatible nanomaterials in food science, technology, and nutrient drug delivery: recent developments and applications. Frontiers in Nutrition. 2022, 8: 778155.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




